BNP Paribas Financial Markets Purchases 36,920 Shares of The Ensign Group, Inc. $ENSG

BNP Paribas Financial Markets increased its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 52.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 107,673 shares of the company’s stock after buying an additional 36,920 shares during the quarter. BNP Paribas Financial Markets’ holdings in The Ensign Group were worth $18,757,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Equitable Trust Co. grew its position in The Ensign Group by 260.5% in the 3rd quarter. Equitable Trust Co. now owns 29,026 shares of the company’s stock worth $5,015,000 after purchasing an additional 20,975 shares during the period. Mitsubishi UFJ Trust & Banking Corp lifted its stake in The Ensign Group by 52.5% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 54,336 shares of the company’s stock worth $9,465,000 after purchasing an additional 18,699 shares in the last quarter. Citigroup Inc. lifted its stake in The Ensign Group by 16.6% in the 3rd quarter. Citigroup Inc. now owns 56,612 shares of the company’s stock worth $9,781,000 after purchasing an additional 8,056 shares in the last quarter. Cypress Wealth Services LLC purchased a new stake in The Ensign Group in the 4th quarter worth $1,508,000. Finally, Segall Bryant & Hamill LLC increased its holdings in shares of The Ensign Group by 2.3% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 331,596 shares of the company’s stock worth $57,290,000 after buying an additional 7,495 shares during the last quarter. 96.12% of the stock is currently owned by hedge funds and other institutional investors.

The Ensign Group Price Performance

Shares of ENSG opened at $170.30 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.56 and a quick ratio of 1.56. The stock has a market cap of $9.95 billion, a PE ratio of 27.74, a P/E/G ratio of 1.61 and a beta of 0.68. The firm has a 50-day simple moving average of $184.82 and a two-hundred day simple moving average of $187.70. The Ensign Group, Inc. has a 1-year low of $134.79 and a 1-year high of $218.00.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The firm had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.40 billion. During the same quarter in the previous year, the business posted $1.52 earnings per share. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, analysts forecast that The Ensign Group, Inc. will post 6.79 EPS for the current year.

The Ensign Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st were given a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Tuesday, March 31st. The Ensign Group’s payout ratio is currently 4.23%.

Insider Activity at The Ensign Group

In other news, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the sale, the director owned 9,295 shares in the company, valued at approximately $1,858,721.15. The trade was a 4.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the sale, the director owned 21,352 shares of the company’s stock, valued at $3,507,706.56. This represents a 3.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,592 shares of company stock valued at $478,246 in the last 90 days. Insiders own 4.00% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on ENSG shares. UBS Group set a $230.00 price target on shares of The Ensign Group and gave the company a “buy” rating in a report on Friday, February 6th. Weiss Ratings reissued a “buy (b)” rating on shares of The Ensign Group in a research report on Tuesday, April 21st. Royal Bank Of Canada restated an “outperform” rating and set a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Wall Street Zen lowered shares of The Ensign Group from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Truist Financial set a $215.00 price objective on shares of The Ensign Group and gave the stock a “hold” rating in a research note on Friday, February 6th. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $216.75.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.